Ocular Therapeutix Inc (OCUL)
6.18
-0.09
(-1.44%)
USD |
NASDAQ |
May 17, 16:00
6.18
0.00 (0.00%)
After-Hours: 20:00
Ocular Therapeutix Revenue (Annual): 58.44M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 58.44M |
| December 31, 2022 | 51.49M |
| December 31, 2021 | 43.52M |
| December 31, 2020 | 17.40M |
| December 31, 2019 | 4.227M |
| December 31, 2018 | 1.99M |
| Date | Value |
|---|---|
| December 31, 2017 | 1.923M |
| December 31, 2016 | 1.887M |
| December 31, 2015 | 1.75M |
| December 31, 2014 | 0.772M |
| December 31, 2013 | |
| December 31, 2012 | 0.01M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
4.227M
Minimum
2019
58.44M
Maximum
2023
35.02M
Average
43.52M
Median
2021
Revenue (Annual) Benchmarks
| Amgen Inc | 28.19B |
| Assertio Holdings Inc | 152.07M |
| CytomX Therapeutics Inc | 101.21M |
| EyePoint Pharmaceuticals Inc | 46.02M |
| Cormedix Inc | -- |